Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|December 22, 2023
Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIVJosé M Benito, Clara Restrepo, Jesús García-Foncillas, et al.Reviews in Medical Virology|May 11, 2018
Peering into the HIV reservoirMarcial García, María J Buzón, José M Benito, et al.The Journal of Antimicrobial Chemotherapy|July 9, 2013
Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemiaNorma Rallón, José M Sempere-Ortells, Vincent Soriano, et al.Frontiers in Immunology|January 21, 2022
Extracellular Vesicles as a New Promising Therapy in HIV InfectionMaria A Navarrete-Muñoz, Carlos Llorens, José M Benito, et al.Virulence|July 24, 2020
Elite controllers: A heterogeneous group of HIV-infected patientsMaría A Navarrete-Muñoz, Clara Restrepo, José M Benito, et al.The Journal of Antimicrobial Chemotherapy|December 24, 2011
Pharmacogenetics of hepatitis CVincent Soriano, Eva Poveda, Eugenia Vispo, et al.AIDS Research and Human Retroviruses|October 23, 2010
Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAARTMariola López, Vincent Soriano, Alejandra Peris-Pertusa, et al.European Journal of Immunology|April 19, 2008
Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cellsMariola López, Vincent Soriano, Norma Rallón, et al.AIDS (London, England)|January 3, 2012
Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravirCarolina Garrido, Norma Rallón, Vincent Soriano, et al.Virulence|October 3, 2022
High frequency of CD8 escape mutations in elite controllers as new obstacle for HIV cureMaría A Navarrete-Muñoz, Ricardo Ramos, África Holguín, et al.Pageof 7